Chicago Drugmaker Recalls Neuromuscular Drug Due to Labeling Error
News brief about recall of cisatracurium due to some vials in lot being incorrectly labeled as phenylephrine mentions ISMP’s alert to practitioners as well as Food and Drug Administration (FDA) news release.
For the full text, visit Becker’s Hospital Review online.
New solution helps organizations prepare frontline staff with essential safety knowledge
Respondents indicated MERP helped reduce risk, increase reporting, justify MSO positions
This article appeared on the Pharmacy Practice News website on April 12, 2023.